A rare mutation in SMAD9 associated with high bone mass identifies the SMAD-dependent BMP signalling pathway as a potential anabolic target for osteoporosis.
Novel anabolic drug targets are needed to treat osteoporosis. Having established a large national cohort with unexplained high bone ma...
